Alkem Laboratories Ltd
NSE:ALKEM

Watchlist Manager
Alkem Laboratories Ltd Logo
Alkem Laboratories Ltd
NSE:ALKEM
Watchlist
Price: 5 599 INR -1.35% Market Closed
Market Cap: 669.4B INR

Alkem Laboratories Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Alkem Laboratories Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Alkem Laboratories Ltd
NSE:ALKEM
Cash from Operating Activities
₹18.1B
CAGR 3-Years
29%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash from Operating Activities
₹58.8B
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash from Operating Activities
₹42.9B
CAGR 3-Years
14%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash from Operating Activities
₹127.2B
CAGR 3-Years
46%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Lupin Ltd
NSE:LUPIN
Cash from Operating Activities
₹47.3B
CAGR 3-Years
N/A
CAGR 5-Years
146%
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash from Operating Activities
₹19.4B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
N/A
No Stocks Found

Alkem Laboratories Ltd
Glance View

Alkem Laboratories Ltd., founded in 1973, has emerged as a significant player in India's pharmaceutical landscape, deftly combining innovation with a robust distribution network. Anchored in Mumbai, Alkem began as a modest venture but quickly evolved into a powerhouse, renowned for manufacturing a broad spectrum of branded generics, over-the-counter products, and active pharmaceutical ingredients (APIs). The company's success lies in its ability to cater to both domestic and international markets, primarily thriving on the ever-increasing demand for affordable healthcare solutions. Its formidable market presence in India is supported by a strong sales force and an extensive distribution network, ensuring its therapies reach even the most remote corners of the country. Internationally, Alkem has carved a niche for itself, with the United States being one of its major export markets. It strategically entered this competitive arena, building a portfolio of ANDAs (Abbreviated New Drug Applications) that allowed it to provide lower-cost alternatives to big pharma's patented drugs. This not only fueled its revenue growth but also fortified its standing as a go-to source for quality generics. Alkem's research and development efforts underpin its commitment to healthcare innovation, as it constantly seeks to expand its therapeutic repertoire. By consistently focusing on quality, affordability, and resourceful adaptation to global healthcare needs, Alkem Laboratories Ltd. has managed to script a growth story that is both impressive and sustainable.

ALKEM Intrinsic Value
HIDDEN
Show

See Also

What is Alkem Laboratories Ltd's Cash from Operating Activities?
Cash from Operating Activities
18.1B INR

Based on the financial report for Sep 30, 2025, Alkem Laboratories Ltd's Cash from Operating Activities amounts to 18.1B INR.

What is Alkem Laboratories Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
10%

Over the last year, the Cash from Operating Activities growth was -8%. The average annual Cash from Operating Activities growth rates for Alkem Laboratories Ltd have been 29% over the past three years , 10% over the past five years .

Back to Top